Add
AEMD.OB to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| AEMD.OB > SEC Filings for AEMD.OB > Form 8-K on 25-Jul-2008 | All Recent SEC Filings |
25-Jul-2008
Other Events, Financial Statements and Exhibits
On July 24, 2008, James A. Joyce, the Company's Chief Executive Officer, acquired 100,000 shares of common stock at the closing market price of $0.35 per share in exchange for forgiveness of debt. The debt was incurred in prior years and related to salary and expenses. The conversion was memorialized in a letter agreement with Company and approved by the Board of Directors, dated July 24, 2008. These securities were issued in reliance upon an exemption from registration pursuant to Section 4(2) of the Securities Act of 1933.
(d) EXHIBITS
ITEM NO. DESCRIPTION
10.1 Letter agreement between Aethlon Medical, Inc. and James A. Joyce
|
|